ASML Holding(ASML) - 2026 Q1 - Earnings Call Presentation
2026-04-15 13:00
ASML reports €8.8 billion total net sales and €2.8 billion net income in Q1 2026 ASML now expects 2026 total net sales to be between €36 billion and €40 billion, with a gross margin between 51% and 53% ASML 2026 first-quarter results Veldhoven, the Netherlands April 15, 2026 Agenda April 15, 2026 Page 2 Public • Investor key messages • Business summary • Outlook • Financial statements Investor key messages April 15, 2026 Page 3 Investor key messages1 April 15, 2026 Page 4 1 Investor key messages as presente ...
FGI Industries .(FGI) - 2025 Q4 - Earnings Call Presentation
2026-04-09 13:00
Investor Fourth Quarter 2025 Presentation Disclaimer Certain matters discussed in this presentation contain forward-looking statements concerning our business, operations and financial performance and conditions, as well as our plans, objectives and expectations for our business operations and financial performance and condition. These statements may be preceded by, followed by or include the words "may," "expect," "will," "will likely result," "should," "estimate," "plan" and other similar expressions that ...
LIXIL (OTCPK:JSGR.Y) 2026 Earnings Call Presentation
2026-04-03 05:00
LIXIL IMPACT BRIEFING: April 3, 2026 Empowering Change: Scaling Impact in a New Era Copyright © LIXIL Corporation. All rights reserved. Today's Speakers Kinya Seto Director, Representative Executive Officer, President, and Chief Executive Officer Erin McCusker Executive Officer, Executive Vice President, Chief Impact Officer, Communications, External Affairs, and Impact Strategy 1 Outside Director, Chairperson of the Board of Directors and Chairperson of Governance Committee Ryusuke Ohori ––––– Outside Dire ...
Akebia Therapeutics (NasdaqCM:AKBA) 2026 Earnings Call Presentation
2026-04-02 14:00
R&D Day 2026 April 2, 2026 Bettering the Lives of People Impacted by Kidney Disease NASDAQ: AKBA 1 Cautionary note on forward-looking statements Statements in this presentation regarding Akebia Therapeutics, Inc.'s ("Akebia's") strategy, plans, prospects, expectations, beliefs, intentions and goals are forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, as amended, and include, but are not limited to, statements regarding: Akebia's plans, strategies an ...
AngioDynamics(ANGO) - 2026 Q3 - Earnings Call Presentation
2026-04-02 12:00
Third Quarter FY 2026 Earnings Results April 2, 2026 Forward looking statements Notice Regarding Forward-Looking Statements This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements regarding AngioDynamics' expected future financial position, results of operations, cash flows, business strategy, budgets, projected costs, capital expenditures, products, competitive positions, growth opportunities, plans and objectives of m ...
LEG Immobilien (OTCPK:LEGI.F) Earnings Call Presentation
2026-04-01 08:00
LEG Immobilien SE Company Presentation April 2026 FY 2025 Company Presentation 1 FY-2025 Highlights Company Presentation March 2026 – LEG Immobilien SE 2 2 LEG at a Glance 3 Portfolio & Operations 4 Management 5 ESG 6 Financials 7 Financing Share information, Financial calendar & IR contact 8 LEG Immobilien SE Disclaimer LEG Immobilien SE ("The Company") has taken all reasonable care to ensure that the facts stated in this presentation are accurate and that the opinions expressed therein are fair and reason ...
XBP Europe (XBP) - 2025 Q4 - Earnings Call Presentation
2026-03-31 21:00
©XBP GLOBAL 2026 PROPRIETARY & CONFIDENTIAL 1 Safe Harbor Statements About Pro Forma Financial Information Fourth Quarter & Full Year 2025 Financial Results Andrej Jonovic, Chief Executive Officer Dejan Avramovic, Chief Financial Officer For financial reporting purposes, Exela BPA is treated as the accounting acquirer, and results exclude the results of our European operations (" XBP Europe") until July 31, 2025. As a result, reported results for periods prior to July 31, 2025 are not comparable to previous ...
Aqua Metals(AQMS) - 2025 Q4 - Earnings Call Presentation
2026-03-31 20:30
IN CLEAN METALS & BATTERY RECYCLING NASDAQ: AQMS 2026 Copyright © 2026 Aqua Metals, Inc. All Rights Reserved. Copyright © 2026 Aqua Metals, Inc. All Rights Reserved. DISCLAIMER This presentation contains forward-looking statements concerning Aqua Metals, Inc. Forward-looking statements include, but are not limited to, our plans, objectives, expectations and intentions and other statements that contain words such as "expects," "contemplates," "anticipates," "plans," "intends," "believes", "estimates", "poten ...
nCino(NCNO) - 2026 Q4 - Earnings Call Presentation
2026-03-31 20:30
all March 31, 2026 Cautionary Note Regarding Forward-Looking Statements, Disclaimers and Financial Measures This presentation contains forward-looking statements about nGind sofinanced and operating results, which hivalude statements regarding nCiro's future performance, cutock, the cosumptions underlying those statements, the benefits from the use of nCino's solutions, our stratespes, and general business conditions. Forward-lecking statements gen actions, events, realits, strategies and expectations and a ...
Banzai International(BNZI) - 2025 Q4 - Earnings Call Presentation
2026-03-31 20:30
AI-Powered Marketing Technology Solutions Q4 and FY 2025 Financial Results Conference Call March 31, 2026 NASDAQ: BNZI Disclaimers No Offer or Solicitation This Presentation and any oral statements made in connection with this Presentation do not constitute an offer to sell, or a solicitation of an offer to buy, or a recommendation to purchase, any securities of the Company in any jurisdiction, nor shall there be any sale, issuance or transfer of any securities of the Company in any jurisdiction where, or t ...